ABOUT US

Make probiotics the foundation of a longer, healthier life - for all
This idea accompanies every single Kijimea product. From research, through development, all the way to you.

Mikrobiom Bild

Kijimea – the pioneer in probiotic medicine

Kijimea is a leading probiotic brand from Germany. For over a decade, Kijimea has been
conducting research in the field of gut health and the microbiome and
developing preparations with the highest level of clinical evidence. Kijimea's
goal is to make probiotics the foundation of a longer, healthier life – for
everyone.

Kijimea now has more than 10 million satisfied customers across Europe. People in more than
10 countries, including Germany, Italy, France, the United Kingdom, Sweden and
Poland, already trust Kijimea. Within the next 12 months, Kijimea will also be
available in many other countries outside Europe.

Our mission is to become the world's largest probiotics company by 2030. Every day, the
latest scientific findings on the microbiome spur us on to achieve excellence.

The Kijimea philosophy

As a probiotic brand, Kijimea recognised the potential of the human microbiome at a time when few others were paying attention to it. The founders of Kijimea, Dr
Clemens Fischer and Madlena Hohlefelder, had a vision early on to improve the
quality of life for millions of people based on these findings.

Even though Kijimea has grown from small beginnings to become a leading company in the pharmacy and online market, one thing has never changed: Kijimea is uncompromising in its commitment to gold standard scientific studies – double-blind, placebo-controlled and randomised – for the well-being of its customers. This rigorous scientific approach is also
firmly rooted in our corporate philosophy: ‘ Proven by
science. Designed for life.’



Mikrobiom Bild

Kijimea products: Proven by science. Designed for life.

The Kijimea product portfolio now includes over 15 products that support our customers in
every situation. In addition to healthy digestion, these include important
topics such as women's health, skin health and general well-being.

We are particularly proud of your favourites:

  • With our unique medical product Kijimea IBS PRO, which contains the patented bacterial strain B. bifidum HI-MIMBb75, we have already been able to give 10 million people suffering from irritable bowel syndrome a better life.

  • Our unrivalled, highly diverse and high-dose broad-spectrum multi-biotic Kijimea K53 Advance marks a
    breakthrough in the microculture preparation market, having helped over 1 million customers achieve their health goals to date. With its multitude and diversity of bacteria, it is unique on the market and mimics the natural microbiome in an unrivalled way.

  • Kijimea FloraCare: A preparation that not only contains 33 specifically selected strains of lactobacilli, but also supports
    the structure and function of the vaginal mucosa with riboflavin. Although Kijimea FloraCare was only launched in 2024, over 100,000 women have already opted for this innovative microculture preparation.

This is what Kijimea values

Own research

We maintain long-term, personal partnerships with microbiome researchers and research institutions worldwide, including Charité in Berlin. To achieve the most accurate results possible, we rely exclusively on gold standard research.

 

Scientific evidence

No bacterial strain in our preparations is a random product. Based on scientific evidence, we specifically select specific bacterial strains to combine them for the best possible effect. In addition, our finished products are scientifically tested.

 

Highest Quality

From the selection of ingredients to packaging, Kijimea adheres to standards that are far higher than those generally required. Our products are manufactured in
Europe and each batch is tested to ensure that you receive a safe and stable
product.

A written article from the Lancet

Dr. Clemens Fischer Bild
Dr. Clemens Fischer
Founder & CEO FUTRUE
Madlena Hohlefelder Bild
Madlena Hohlefelder
Founder & CSO FUTRUE

Kijimea – Our founders

Kijimea – Our founders

‘While groundbreaking advances are being made in areas such as artificial intelligence
and space travel, the healthcare sector is largely stagnating despite isolated
successes. It is high time for fundamental change.’

Kijimea's success can be traced back to the ambition of two visionaries who were no
longer willing to accept the status quo in the healthcare industry: Dr Clemens
Fischer and Madlena Hohlefelder. They were driven by their fascination with the
human microbiome. They recognised that although the research on the importance
of bacteria in our intestines was impressive, this knowledge had hardly been
utilised to date.

What began in Munich has now become a global success story. With the development of the leading medical product for irritable bowel syndrome, the two founders and
their teams achieved their first major milestone years ago. Today, Kijimea
pursues its founders' vision with a wide range of products: to make probiotics
the basis for a longer, healthier life.

Dr. Clemens Fischer
Gründer & CEO FUTRUE
Madlena Hohlefelder
Gründerin & CSO FUTRUE
10
In 10 European countries and others are in the process of being established
10million
Satisfied customers
100
Evidence-based